Experimental Hematogenous Infection of Subcutaneously Implanted Foreign Bodies

References

• . Charnley J. Postoperative infection after total hip replacement with special reference to air contamination in the operating room. Clin Orthop 87: 167–187, 1972.
   PubMedGoogle Scholar
• . Lidwell OM, Lowbury EJL, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: A randomised study. Br Med J 285: 10–14, 1982.
   PubMed Web of Science ®Google Scholar
• . Courtiss EH, Goldwyn RM, Anastasi GW. The fate of breast implants with infections around them. Plast Reconstr Surg 63: 812–816, 1979.
   PubMed Web of Science ®Google Scholar
• . Bernhard VM. Management of infected vascular prostheses. Surg Clin N Am 55: 1411–1417, 1975.
   PubMed Web of Science ®Google Scholar
• . Bath DJ, Tellis VA, Kohlberg WI, Driscoll B, Veith FJ. Management of sepsis involving expanded polytetrafluorethylene grafts for hemodialysis access. Surgery 87: 445–450, 1980.
   PubMed Web of Science ®Google Scholar
• . Georgiade NG, King EH, Harris WA, Tenery JH, Schlech BA. Effect of three proteinaceous foreign materials on infected and subinfected wound models. Surgery 77: 569–576, 1975.
   PubMed Web of Science ®Google Scholar
• . Christensen GD, Bisno AL, Parisi JT, McLaughlin B, Hester MG, Luther RW. Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med 96: 1–10, 1982.
   PubMed Web of Science ®Google Scholar
• . Rubin J, Rogers WA, Taylor HM, Everett ED, Prowant BF, Fruto LV, Nolph KD. Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med 92: 7–13, 1980.
   PubMed Web of Science ®Google Scholar
• . Dougherty SH, Simmons RL. Infections in bionic man: The pathobiology of infections in prosthetic devices. Curr Probl Surg 19: 219–319, 1982.
   Google Scholar
• . Buchholz HW, Elson RA, Engelbrecht E, Lodenkämper H, Röttger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg 63-B: 342–353, 1981.
   Web of Science ®Google Scholar
• . Ahlberg A, Carlsson AS, Lindberg L. Hematogenous infection in total joint replacement. Clin Orthop 137: 69–75, 1978.
   Google Scholar
• . Burton DS, Schurman DJ. Hematogenous infection in bilateral total hip arthroplasty. J Bone Joint Surg 57-A: 1004–1005, 1975.
   Web of Science ®Google Scholar
• . Downes EM. Late infection after total hip replacement. J Bone Joint Surg 59-B: 42–44, 1977.
   Web of Science ®Google Scholar
• . Lattimer GL, Keblish PA, Dickson TB, Vernick CG, Finnegan WJ. Hematogenous infection in total joint replacement. JAMA 242: 2213–2214, 1979.
   PubMed Web of Science ®Google Scholar
• . Wigren A, Karlström G, Kaufer H. Hematogenous infection of total joint implants: A report of multiple joint infections in three patients. Clin Orthop 152: 288–291, 1980.
   Google Scholar
• . Blomgren G, Lindgren U. The susceptibility of total joint replacement to hematogenous infection in the early postoperative period. Clin Orthop 151: 308–312, 1980.
   Google Scholar
• . Blomgren G, Lundquist H, Nord CE, Lindgren U. Late anaerobic haematogenous infection of experimental total joint replacement. J Bone Joint Surg 63-B: 614–618, 1981.
   Web of Science ®Google Scholar
• . Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man. A study of the problems of wound infection. Br J Exp Pathol 38: 573–586, 1957.
   PubMed Web of Science ®Google Scholar
• . Grogan EL, Sande MA, Clark RE, Nolan SP. Experimental endocarditis in calf after tricuspid valve replacement. Ann Thorac Surg 30: 64–69, 1980.
   PubMed Web of Science ®Google Scholar
• . Serota AI, Williams RA, Rose JG, Wilson SE. Uptake of radiolabeled leukocytes in prosthetic graft infection. Surgery 90: 35–40, 1981.
   PubMed Web of Science ®Google Scholar
• . Tshefu K, Zimmerli W, Waldvogel FA. Short-term administration of rifampin in the prevention or eradication of infection due to foreign bodies. Rev Infect Dis 5, Suppl: S474–S480, 1983.
   PubMedGoogle Scholar
• . Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection: Evidence for a local granulocyte defect. J Clin Invest 73: 1191–1200, 1984.
   PubMed Web of Science ®Google Scholar
• . Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection: Description and characteristics of an animal model. J Infect Dis 146: 487–497, 1982.
   PubMed Web of Science ®Google Scholar
• . Holm SE, Ekedahl C, Bergholm AM. Comparison of antibiotic assays using different experimental models and their possible clinical significance. Scand J Infect Dis, Suppl 14: 214–220, 1978.
   Google Scholar
• . Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296: 1305–1309, 1977.
   PubMed Web of Science ®Google Scholar
• . Williams JD, Leung T. Rifamycins. In: Reeves DS, Phillips I, Williams JD, Wise R, eds. Laboratory methods in antimicrobial chemotherapy. Edinburgh: Churchill Livingstone, 239–243, 1978.
   Google Scholar
• . Pankey GA. The prevention and treatment of bacterial endocarditis. Am Heart J 98: 102–118, 1979.
   PubMed Web of Science ®Google Scholar
• . Sande MA. The use of rifampin in the treatment of nontuberculous infections: An overview. Rev Infect Dis 5, Suppl: S399–S401, 1983.
   Google Scholar
• . Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: Epidemiology, clinical manifestations, and therapy. J Infect Dis 131: 543–552, 1975.
   PubMed Web of Science ®Google Scholar
• . Everett ED, Hirschmann JV. Transient bacteremia and endocarditis prophylaxis. A review. Medicine 56: 61–77, 1977.
   PubMed Web of Science ®Google Scholar
• . Gwynn MN, Webb LT, Robinson GN. Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other beta-lactam antibiotics. J Infect Dis 144: 263–269, 1981.
   PubMed Web of Science ®Google Scholar
• . Archer GL, Johnston JL, Vazquez GJ, Haywood III HB. Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: In vitro and in vivo studies. Rev Infect Dis 5, Suppl: S538–S542, 1983.
   PubMedGoogle Scholar
• . Mandell GL, Moorman DR. Treatment of experimental staphylococcal infections: Effect of rifampin alone and in combination on development of rifampin resistance. Antimicrob Agents Chemother 17: 658–662, 1980.
   PubMed Web of Science ®Google Scholar
• . Norden CW. Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin. J Infect Dis 132: 493–499, 1975.
   PubMed Web of Science ®Google Scholar
• . Sande MA, Johnson ML. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis 131: 367–375, 1975.
   PubMed Web of Science ®Google Scholar